APA (7th ed.) Citation

Chimalakonda, A., Li, W., Marchisin, D., He, B., Singhal, S., Deshpande, P., . . . Murthy, B. (2023). Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans. Clinical pharmacology in drug development, 12(10), 956-965. https://doi.org/10.1002/cpdd.1308

Chicago Style (17th ed.) Citation

Chimalakonda, Anjaneya, Wenying Li, David Marchisin, Bing He, Shalabh Singhal, Prashant Deshpande, Jonathan Brown, Urvi Aras, and Bindu Murthy. "Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans." Clinical Pharmacology in Drug Development 12, no. 10 (2023): 956-965. https://doi.org/10.1002/cpdd.1308.

MLA (9th ed.) Citation

Chimalakonda, Anjaneya, et al. "Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans." Clinical Pharmacology in Drug Development, vol. 12, no. 10, 2023, pp. 956-965, https://doi.org/10.1002/cpdd.1308.